Precipitation Inhibition by Small-Molecule Analogues To Sustain Drug Supersaturation

Area of Science:

• Pharmaceutical Sciences
• Physical Chemistry
• Drug Delivery

Background:

• Maintaining drug supersaturation during gastrointestinal pH changes is crucial for oral bioavailability of pH-sensitive drugs.
• Classical precipitation inhibitors like hypromellose (HPMC) and polyvinylpyrrolidone (PVP) have limitations in stabilizing supersaturation.

Purpose of the Study:

• To investigate the use of structurally related fluoroquinolone analogues as nucleation inhibitors to stabilize ciprofloxacin supersaturation.
• To compare the efficacy of these analogues with traditional polymeric precipitation inhibitors.

Main Methods:

• Structural similarity screening to identify candidate nucleation inhibitors.
• Evaluation using nucleation induction time, dynamic pH-shift dissolution, and 1H NMR spectroscopy.
• Assessment of drug concentration and area under the curve (AUC) during dissolution studies.

Main Results:

• Danofloxacin significantly extended ciprofloxacin nucleation induction time, outperforming HPMC and PVP.
• Danofloxacin and levofloxacin sustained high ciprofloxacin concentrations (92% and 37%) at pH 7.0, compared to ciprofloxacin alone (20%).
• 1H NMR confirmed heteroassociation between ciprofloxacin and analogues, with danofloxacin showing the most significant effect.

Conclusions:

• Small-molecule structural mimicry is a viable strategy for stabilizing drug supersaturation.
• Isostructural analogues kinetically inhibit ciprofloxacin self-association and delay prenucleation aggregate formation.
• This approach offers a mechanism-based design for coformulating pH-sensitive drugs to enhance oral exposure.